combined metabolic cofactor supplementation accelerates mortality in mild-to-moderate covid-19
combined metabolic cofactor supplementation accelerates mortality in mild-to-moderate covid-19
methods we conducted a placebo-controlled, phase-2 clinical trial involving ambulatory covid-19 patients.", "combined metabolic cofactors supplementation (cmcs) consisting of l-serine, n-acetyl-l-cysteine (nac), nicotinamide riboside (nr), and l-carnitine tartrate is being studied for the treatment of patients with covid-19.", "conclusions in patients with mild-to-moderate covid-19, cmcs resulted in a significant reduction in recovery time and liver enzymes associated with hepatic function compared to placebo."


































)